Biotechnology Ultrasector Price To Book vs. Three Year Return

BIPSX Fund  USD 41.58  1.07  2.51%   
Considering Biotechnology Ultrasector's profitability and operating efficiency indicators, Biotechnology Ultrasector Profund may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess Biotechnology Ultrasector's ability to earn profits and add value for shareholders.
For Biotechnology Ultrasector profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biotechnology Ultrasector to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biotechnology Ultrasector Profund utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biotechnology Ultrasector's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biotechnology Ultrasector Profund over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Biotechnology Ultrasector's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biotechnology Ultrasector is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biotechnology Ultrasector's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biotechnology Ultrasector Three Year Return vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Biotechnology Ultrasector's current stock value. Our valuation model uses many indicators to compare Biotechnology Ultrasector value to that of its competitors to determine the firm's financial worth.
Biotechnology Ultrasector Profund is second largest fund in price to book among similar funds. It is third largest fund in three year return among similar funds reporting about  0.60  of Three Year Return per Price To Book. The ratio of Price To Book to Three Year Return for Biotechnology Ultrasector Profund is roughly  1.67 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotechnology Ultrasector's earnings, one of the primary drivers of an investment's value.

Biotechnology Three Year Return vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Biotechnology Ultrasector

P/B

 = 

MV Per Share

BV Per Share

 = 
5.19 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.

Biotechnology Ultrasector

Three Year Return

 = 

(Mean of Monthly Returns - 1)

X

100%

 = 
3.10 %
Although Three Year Fund Return indicator can give a sense of overall fund mid-term potential, it is recommended to compare fund performances against other similar funds, ETFs, or market benchmarks for the same 3 year interval.

Biotechnology Three Year Return Comparison

Biotechnology Ultrasector is currently under evaluation in three year return among similar funds.

Biotechnology Ultrasector Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Biotechnology Ultrasector, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biotechnology Ultrasector will eventually generate negative long term returns. The profitability progress is the general direction of Biotechnology Ultrasector's change in net profit over the period of time. It can combine multiple indicators of Biotechnology Ultrasector, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
The fund invests in financial instruments that the fund advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index represents the biotechnology segment of the SP Total Market Index, which comprises the following sub-industry biotechnology. The fund is non-diversified.

Biotechnology Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Biotechnology Ultrasector. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biotechnology Ultrasector position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biotechnology Ultrasector's important profitability drivers and their relationship over time.

Use Biotechnology Ultrasector in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biotechnology Ultrasector position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Ultrasector will appreciate offsetting losses from the drop in the long position's value.

Biotechnology Ultrasector Pair Trading

Biotechnology Ultrasector Profund Pair Trading Analysis

The ability to find closely correlated positions to Biotechnology Ultrasector could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biotechnology Ultrasector when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biotechnology Ultrasector - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biotechnology Ultrasector Profund to buy it.
The correlation of Biotechnology Ultrasector is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biotechnology Ultrasector moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biotechnology Ultrasector moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biotechnology Ultrasector can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Biotechnology Ultrasector position

In addition to having Biotechnology Ultrasector in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Energy Funds Thematic Idea Now

Energy Funds
Energy Funds Theme
Funds or Etfs investing in energy sector, natural resources, and ecology. The Energy Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Biotechnology Mutual Fund

To fully project Biotechnology Ultrasector's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Biotechnology Ultrasector at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Biotechnology Ultrasector's income statement, its balance sheet, and the statement of cash flows.
Potential Biotechnology Ultrasector investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Biotechnology Ultrasector investors may work on each financial statement separately, they are all related. The changes in Biotechnology Ultrasector's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Biotechnology Ultrasector's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
CEOs Directory
Screen CEOs from public companies around the world